Goodman Jesse
Intellia Therapeutics, Inc. · Director
Goodman Jesse is listed in filings as Director at Intellia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2025, including sale activity. Recent filings connect the profile to Intellia Therapeutics, Inc. (NTLA) and BiomX Inc. (PHGE). The current snapshot covers public activity from Jun 14, 2024 to Jul 2, 2025. Reported amounts are shown as $14.3K to $95.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $14k1.5k shares | SellJul 1, 2025 | $9.23 | $13.04 |